Factors determining colorectal cancer: The role of the intestinal microbiota

Frontiers in Oncology

Volumn 5, Issue OCT, 2015, Pages

  Nistal, Esther ^a   Fernández Fernández, Nereida ^b   Vivas, Santiago ^a,b   Olcoz, José Luis ^b  

^a UNIVERSITY OF LEÓN   (Spain)

^b HOSPITAL UNIVERSITARIO DE LEÓN   (Spain)

Author keywords

Bacterial metabolites; Colorectal cancer; Diet; Gut microbiota; Inflammation

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 23; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; RNA 16S; SOMATOMEDIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACTINOBACTERIA; ALCOHOL CONSUMPTION; BACTEROIDETES; CANCER GROWTH; CELL CYCLE REGULATION; CHRONIC INFLAMMATION; COLORECTAL CANCER; DYSBIOSIS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FIRMICUTES; FUNCTIONAL STATUS; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS JOHNSONII; LIFE EXPECTANCY; MOLECULAR PHYLOGENY; NEXT GENERATION SEQUENCING; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEDENTARY LIFESTYLE; STREPTOCOCCUS GALLOLYTICUS; TOBACCO; VERRUCOMICROBIA; WESTERN DIET;

EID: 84947049266     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00220     Document Type: Review

References (130)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2015) 136:E359-86. doi: 10.1002/ijc.29210
2. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer (2007) 96:828-31. doi:10.1038/sj.bjc.6603628
3. Etxeberria J, Ugarte MD, Goicoa T, Militino AF. Age-and sex-specific spatio-temporal patterns of colorectal cancer mortality in Spain (1975-2008). Popul Health Metr (2014) 12:17. doi:10.1186/1478-7954-12-17
4. Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, et al. Recent trends in colorectal cancer mortality in Europe. Int J Cancer (2011) 129:180-91. doi:10.1002/ijc.25653
5. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 18:1688-94. doi:10.1158/1055-9965.EPI-09-0090
6. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 59:366-78. doi:10.3322/caac.20038
7. Migliore L, Migheli F, Spisni R, Coppede F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol (2011) 2011:792362. doi:10.1155/2011/792362
8. Hoffmeister M, Schmitz S, Karmrodt E, Stegmaier C, Haug U, Arndt V, et al. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol (2010) 8:870-6. doi:10.1016/j.cgh.2010.07.004
9. Hassan C, Pickhardt PJ, Marmo R, Choi JR. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis Colon Rectum (2010) 53:1328-33. doi:10.1007/DCR.0b013e3181e10daa
10. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 66:1191-308.
11. O'Keefe SJ, Kidd M, Espitalier-Noel G, Owira P. Rarity of colon cancer in Africans is associated with low animal product consumption, not fiber. Am J Gastroenterol (1999) 94:1373-80. doi:10.1111/j.1572-0241.1999.01089.x
12. McMichael AJ, Giles GG. Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res (1988) 48:751-6.
13. Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev (2006) 7:86-90.
14. Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, Newton K, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr (2013) 98:111-20. doi:10.3945/ajcn.112.056689
15. Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol (2014) 20:6055-72. doi:10.3748/wjg.v20.i20.6055
16. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2006) 240:143-7. doi:10.1016/j.canlet.2005.09.004
17. Vargas AJ, Thompson PA. Diet and nutrient factors in colorectal cancer risk. Nutr Clin Pract (2012) 27:613-23. doi:10.1177/0884533612454885
18. Minami Y, Nishino Y, Tsubono Y, Tsuji I, Hisamichi S. Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture, 1959-1997. J Epidemiol (2006) 16:240-8. doi:10.2188/jea.16.240
19. Kim BC, Shin A, Hong CW, Sohn DK, Han KS, Ryu KH, et al. Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control (2012) 23:727-35. doi:10.1007/s10552-012-9942-9
20. Yang MH, Rampal S, Sung J, Choi YH, Son HJ, Lee JH, et al. The association of serum lipids with colorectal adenomas. Am J Gastroenterol (2013) 108:833-41. doi:10.1038/ajg.2013.64
21. Becker S, Dossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem (2009) 115:86-96. doi:10.1080/13813450902878054
22. Bilinski P, Wojtyla A, Kapka-Skrzypczak L, Chwedorowicz R, Cyranka M, Studzinski T. Epigenetic regulation in drug addiction. Ann Agric Environ Med (2012) 19:491-6.
23. Yang T, Owen JL, Lightfoot YL, Kladde MP, Mohamadzadeh M. Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol Med (2013) 19:714-25. doi:10.1016/j.molmed.2013.08.005
24. Curtin K, Slattery ML, Samowitz WS. CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int (2011) 2011:902674. doi:10.4061/2011/902674
25. Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, Ran ZH, et al. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis (2011) 12:234-44. doi:10.1111/j.1751-2980.2011.00504.x
26. Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X, et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol (2013) 178:84-100. doi:10.1093/aje/kws431
27. Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, Anderson K, et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev (2002) 11:541-8.
28. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol (1998) 64:3854-9.
29. Vaughan EE, Schut F, Heilig HG, Zoetendal EG, de Vos WM, Akkermans AD. A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol (2000) 1:1-12.
30. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol (2002) 68:219-26. doi:10.1128/AEM.68.1.219-226.2002
31. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr (2004) 134:465-72.
32. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol (2008) 24:4-10. doi:10.1097/MOG.0b013e3282f2b0e8
33. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet (2003) 361:512-9. doi:10.1016/S0140-6736(03)12489-0
34. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 124:837-48. doi:10.1016/j.cell.2006.02.017
35. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology (2009) 136:65-80. doi:10.1053/j.gastro.2008.10.080
36. Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology (2014) 146:1449-58. doi:10.1053/j.gastro.2014.01.052
37. Guamer F. Role of intestinal flora in health and disease. Nutr Hosp (2007) 22(Suppl 2):14-9.
38. Zhu Y, Michelle Luo T, Jobin C, Young HA. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett (2011) 309:119-27. doi:10.1016/j.canlet.2011.06.004
39. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett (2004) 93:97-108. doi:10.1016/j.imlet.2004.02.005
40. Marchesi JR. Human distal gut microbiome. Environ Microbiol (2011) 13:3088-102. doi:10.1111/j.1462-2920.2011.02574.x
41. Shanahan F. Fiber man meets microbial man. Am J Clin Nutr (2015) 101:1-2. doi:10.3945/ajcn.114.101550
42. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature (2012) 489:242-9. doi:10.1038/nature11552
43. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc (2003) 62:67-72. doi:10.1079/PNS2002207
44. Falony G, Vlachou A, Verbrugghe K, De Vuyst L. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol (2006) 72:7835-41. doi:10.1128/AEM.01296-06
45. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev (2009) 89:147-91. doi:10.1152/physrev.00010.2008
46. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science (2005) 307:1915-20. doi:10.1126/science.1104816
47. Jones ML, Martoni CJ, Ganopolsky JG, Labbe A, Prakash S. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther (2014) 14:467-82. doi:10.1517/14712598.2014.880420
48. Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2015) 308:G351-63. doi:10.1152/ajpgi.00360.2012
49. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun (2008) 76:907-15. doi:10.1128/IAI.01432-07
50. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol (2014) 11:497-505. doi:10.1038/nrgastro.2014.40
51. Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 20:1192-210. doi:10.3748/wjg.v20.i5.1192
52. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut (2004) 53:1-4. doi:10.1136/gut.2004.043372
53. Bajzer M, Seeley RJ. Physiology: obesity and gut flora. Nature (2006) 444:1009-10. doi:10.1038/4441009a
54. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 4:1095-119. doi:10.3390/nu4081095
55. Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res (2012) 32:637-47. doi:10.1016/j.nutres.2012.07.003
56. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One (2012) 7:e39743. doi:10.1371/journal.pone.0039743
57. Dulal S, Keku TO. Gut microbiome and colorectal adenomas. Cancer J (2014) 20:225-31. doi:10.1097/PPO.0000000000000050
58. Nugent JL, McCoy AN, Addamo CJ, Jia W, Sandler RS, Keku TO. Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J Proteome Res (2014) 13:1921-9. doi:10.1021/pr4009783
59. Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 6:1858-68. doi:10.1038/ismej.2012.43
60. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol (2013) 66:462-70. doi:10.1007/s00248-013-0245-9
61. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science (1998) 280:1036-7. doi:10.1126/science.280.5366.1036
62. Bingham SA. Diet and colorectal cancer prevention. Biochem Soc Trans (2000) 28:12-6. doi:10.1042/bst0280012
63. Hope ME, Hold GL, Kain R, El-Omar EM. Sporadic colorectal cancer-role of the commensal microbiota. FEMS Microbiol Lett (2005) 244:1-7. doi:10.1016/j.femsle.2005.01.029
64. Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol (2011) 37:1-14. doi:10.3109/1040841X.2010.501760
65. Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol (2014) 20:908-22. doi:10.3748/wjg.v20.i4.908
66. Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol (2015) 6:20. doi:10.3389/fmicb.2015.00020
67. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 338:120-3. doi:10.1126/science.1224820
68. Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis (2011) 53:870-8. doi:10.1093/cid/cir609
69. Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology (2014) 146:1534.e-46.e. doi:10.1053/j.gastro.2014.01.001
70. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res (2012) 22:299-306. doi:10.1101/gr.126516.111
71. Wang X, Huycke MM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology (2007) 132:551-61. doi:10.1053/j.gastro.2006.11.040
72. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med (2009) 1:6ra14. doi:10.1126/scitranslmed.3000322
73. Fukuda M, Komiyama Y, Mitsuyama K, Andoh A, Aoyama T, Matsumoto Y, et al. Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model. J Clin Biochem Nutr (2011) 49:57-61. doi:10.3164/jcbn.10-114
74. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A (2012) 109:2108-13. doi:10.1073/pnas.1115621109
75. Burns MB, Lynch J, Starr TK, Knights D, Blekhman R. Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med (2015) 7:55. doi:10.1186/s13073-015-0177-8
76. Allali I, Delgado S, Marron PI, Astudillo A, Yeh JJ, Ghazal H, et al. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes (2015) 6:161-72. doi:10.1080/19490976.2015.1039223
77. Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A (2014) 111:18321-6. doi:10.1073/pnas.1406199111
78. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 10:575-82. doi:10.1038/nrmicro2819
79. Medzhitov R. Origin and physiological roles of inflammation. Nature (2008) 454:428-35. doi:10.1038/nature07201
80. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev (2010) 21:11-9. doi:10.1016/j.cytogfr.2009.11.005
81. Ivanov K, Kolev N, Tonev A, Nikolova G, Krasnaliev I, Softova E, et al. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience. Hepatogastroenterology (2009) 56:94-8.
82. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell (2004) 118:285-96. doi:10.1016/j.cell.2004.07.013
83. Guarner F. Enteric flora in health and disease. Digestion (2006) 73(Suppl 1):5-12. doi:10.1159/000089775
84. Hooper C, Jackson SS, Coughlin EE, Coon JJ, Miyamoto S. Covalent modification of the NF-kappaB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro. J Biol Chem (2014) 289:33161-74. doi:10.1074/jbc.M114.582478
85. Tian J, Lin X, Zhou W, Xu J. Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci (2003) 33:451-8.
86. Karrasch T, Kim JS, Muhlbauer M, Magness ST, Jobin C. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol (2007) 178:6522-32. doi:10.4049/jimmunol.178.10.6522
87. Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. MBio (2013) 4:e692-713. doi:10.1128/mBio.00692-13
88. Baxter NT, Zackular JP, Chen GY, Schloss PD. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome (2014) 2:20. doi:10.1186/2049-2618-2-20
89. Dennis KL, Wang Y, Blatner NR, Wang S, Saadalla A, Trudeau E, et al. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res (2013) 73:5905-13. doi:10.1158/0008-5472.CAN-13-1511
90. Azcarate-Peril MA, Sikes M, Bruno-Barcena JM. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol (2011) 301:G401-24. doi:10.1152/ajpgi.00110.2011
91. Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol (2013) 34:1285-300. doi:10.1007/s13277-013-0684-4
92. Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun (2009) 77:1708-18. doi:10.1128/IAI.00814-08
93. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe (2014) 15:317-28. doi:10.1016/j.chom.2014.02.007
94. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci (2008) 65:3756-88. doi:10.1007/s00018-008-8281-1
95. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis (1999) 20:1425-31. doi:10.1093/carcin/20.8.1425
96. Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev (2009) 22:349-69. doi:10.1128/CMR.00053-08
97. Schwabe RF, Wang TC. Cancer. Bacteria deliver a genotoxic hit. Science (2012) 338:52-3. doi:10.1126/science.1229905
98. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A (2010) 107:11537-42. doi:10.1073/pnas.1001261107
99. Duncan SH, Louis P, Flint HJ. Cultivable bacterial diversity from the human colon. Lett Appl Microbiol (2007) 44:343-50. doi:10.1111/j.1472-765X.2007.02129.x
100. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett (2002) 217:133-9. doi:10.1111/j.1574-6968.2002.tb11467.x
101. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol (2011) 17:1519-28. doi:10.3748/wjg.v17.i12
102. Rickard KL, Gibson PR, Wilson NJ, Mariadason JM, Phillips WA. Short-chain fatty acids reduce expression of specific protein kinase C isoforms in human colonic epithelial cells. J Cell Physiol (2000) 182:222-31. doi:10.1002/(SICI)1097-4652(200002)182:2<222:AID-JCP11>3.0.CO;2-B
103. Rombeau JL, Kripke SA. Metabolic and intestinal effects of short-chain fatty acids. JPEN J Parenter Enteral Nutr (1990) 14:181S-5S. doi:10.1177/014860719001400507
104. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev (2010) 23:366-84. doi:10.1017/S0954422410000247
105. Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care (2012) 15:474-9. doi:10.1097/MCO.0b013e32835665fa
106. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int (2012) 95:50-60. doi:10.5740/jaoacint.SGE_Macfarlane
107. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev (2001) 81:1031-64.
108. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr (2002) 132:1012-7.
109. Zhang Y, Zhou L, Bao YL, Wu Y, Yu CL, Huang YX, et al. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact (2010) 185:174-81. doi:10.1016/j.cbi.2010.03.035
110. Tomasello G, Tralongo P, Damiani P, Sinagra E, Di Trapani B, Zeenny MN, et al. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. World J Gastroenterol (2014) 20:18121-30. doi:10.3748/wjg.v20.i48.18121
111. Degirolamo C, Modica S, Palasciano G, Moschetta A. Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol Med (2011) 17:564-72. doi:10.1016/j.molmed.2011.05.010
112. de Giorgio R, Blandizzi C. Targeting enteric neuroplasticity: diet and bugs as new key factors. Gastroenterology (2010) 138:1663-6. doi:10.1053/j.gastro.2010.03.022
113. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol (2012) 3:107. doi:10.3389/fimmu.2012.00107
114. Radley S, Davis AE, Imray CH, Barker G, Morton DG, Baker PR, et al. Biliary bile acid profiles in familial adenomatous polyposis. Br J Surg (1992) 79:89-90. doi:10.1002/bjs.1800790134
115. Nyangale EP, Mottram DS, Gibson GR. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res (2012) 11:5573-85. doi:10.1021/pr300637d
116. Greer JB, O'Keefe SJ. Microbial induction of immunity, inflammation, and cancer. Front Physiol (2011) 1:168. doi:10.3389/fphys.2010.00168
117. Kanazawa K, Konishi F, Mitsuoka T, Terada A, Itoh K, Narushima S, et al. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer (1996) 77:1701-6. doi:10.1002/(SICI)1097-0142(19960415)77:8<1701:AID-CNCR42>3.0.CO;2-0
118. Ramasamy S, Singh S, Taniere P, Langman MJ, Eggo MC. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol (2006) 291:G288-96. doi:10.1152/ajpgi.00324.2005
119. Carbonero F, Benefiel AC, Gaskins HR. Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol (2012) 9:504-18. doi:10.1038/nrgastro.2012.85
120. Loh YH, Jakszyn P, Luben RN, Mulligan AA, Mitrou PN, Khaw KT. N-Nitroso compounds and cancer incidence: the European prospective investigation into cancer and nutrition (EPIC)-norfolk study. Am J Clin Nutr (2011) 93:1053-61. doi:10.3945/ajcn.111.012377
121. Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L, et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr (2011) 93:1062-72. doi:10.3945/ajcn.110.002188
122. Larsson SC, Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer (2006) 119:2657-64. doi:10.1002/ijc.22170
123. Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer (2002) 98:241-56. doi:10.1002/ijc.10126
124. Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev (2001) 10:439-46.
125. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun (2015) 6:6528. doi:10.1038/ncomms7528
126. Clinton SK, Bostwick DG, Olson LM, Mangian HJ, Visek WJ. Effects of ammonium acetate and sodium cholate on N-methyl-N'-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res (1988) 48:3035-9.
127. Gao Z, Guo B, Gao R, Zhu Q, Wu W, Qin H. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. Mol Med Rep (2015) 12(4):6119-27. doi:10.3892/mmr.2015.4124
128. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol (2014) 20:7878-86. doi:10.3748/wjg.v20.i24.7878
129. Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol (2010) 16:167-75. doi:10.3748/wjg.v16.i2.167
130. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer (2005) 116:762-7. doi:10.1002/ijc.21115